​

Funding Round

Series A - Avila Therapeutics

Series A - Avila Therapeutics

Investment Firm

Overview

Avila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases.

Announced Date

Aug 20, 2007

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Abingworth

Abingworth

Abingworth is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorAbingworth
Participant InvestorAtlas Venture
Participant InvestorAdvent Venture Partners
Participant InvestorPolaris Partners

Round Details and Background

Avila Therapeutics raised an undisclosed amount on 2007-08-20 in Series A

Avila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 20, 2007
Series A - Avila Therapeutics
4-undefined
May 14, 2009
Debt Financing - Avila Therapeutics
-5.0M
Jul 27, 2009
Series B - Avila Therapeutics
6-30.0M
Jan 20, 2012
Venture Round - Avila Therapeutics
-4.0M

Recent Activity

There is no recent news or activity for this profile.